Global Tildipirosin API Market Research Report 2023

Publication ID:

PB504244187

Publication Date:

May 4, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Tildipirosin is a semisynthetic derivative of the naturally occurring 16-membered macrolide tylosin. Tildipirosin is intended for parenteral treatment of respiratory disease in cattle and swine.
The global Tildipirosin API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Tildipirosin API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Tildipirosin API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Tildipirosin API include Wuhan Belka Biomedical Co., Ltd., Wuhan Kemilink Chemical Technology Co., Ltd., BOC Sciences, Cayman Chemical Company, Biosynth Carbosynth, Wellman Pharmaceutical Group Co., Ltd., Wuhan Dingxintong Pharmaceutical Co., Ltd., Shanghai Hanxiang Biological Technology Co., Ltd. and MedChemExpress, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tildipirosin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tildipirosin API.
The Tildipirosin API market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Tildipirosin API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tildipirosin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Wuhan Belka Biomedical Co., Ltd.
Wuhan Kemilink Chemical Technology Co., Ltd.
BOC Sciences
Cayman Chemical Company
Biosynth Carbosynth
Wellman Pharmaceutical Group Co., Ltd.
Wuhan Dingxintong Pharmaceutical Co., Ltd.
Shanghai Hanxiang Biological Technology Co., Ltd.
MedChemExpress
Nanjing Kangmanlin Chemical Industry Co., Ltd.
Segment by Type
0.99
0.98
0.95
Segment by Application
Swine
Cattle
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tildipirosin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Tildipirosin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Tildipirosin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Tildipirosin API Market Overview
1.1 Product Definition
1.2 Tildipirosin API Segment by Type
1.2.1 Global Tildipirosin API Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 0.99
1.2.3 0.98
1.2.4 0.95
1.3 Tildipirosin API Segment by Application
1.3.1 Global Tildipirosin API Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Swine
1.3.3 Cattle
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Tildipirosin API Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Tildipirosin API Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Tildipirosin API Production Estimates and Forecasts (2018-2029)
1.4.4 Global Tildipirosin API Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Tildipirosin API Production Market Share by Manufacturers (2018-2023)
2.2 Global Tildipirosin API Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Tildipirosin API, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Tildipirosin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Tildipirosin API Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Tildipirosin API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Tildipirosin API, Product Offered and Application
2.8 Global Key Manufacturers of Tildipirosin API, Date of Enter into This Industry
2.9 Tildipirosin API Market Competitive Situation and Trends
2.9.1 Tildipirosin API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Tildipirosin API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Tildipirosin API Production by Region
3.1 Global Tildipirosin API Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Tildipirosin API Production Value by Region (2018-2029)
3.2.1 Global Tildipirosin API Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Tildipirosin API by Region (2024-2029)
3.3 Global Tildipirosin API Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Tildipirosin API Production by Region (2018-2029)
3.4.1 Global Tildipirosin API Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Tildipirosin API by Region (2024-2029)
3.5 Global Tildipirosin API Market Price Analysis by Region (2018-2023)
3.6 Global Tildipirosin API Production and Value, Year-over-Year Growth
3.6.1 North America Tildipirosin API Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Tildipirosin API Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Tildipirosin API Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Tildipirosin API Production Value Estimates and Forecasts (2018-2029)
4 Tildipirosin API Consumption by Region
4.1 Global Tildipirosin API Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Tildipirosin API Consumption by Region (2018-2029)
4.2.1 Global Tildipirosin API Consumption by Region (2018-2023)
4.2.2 Global Tildipirosin API Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Tildipirosin API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Tildipirosin API Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Tildipirosin API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Tildipirosin API Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Tildipirosin API Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Tildipirosin API Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Tildipirosin API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Tildipirosin API Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Tildipirosin API Production by Type (2018-2029)
5.1.1 Global Tildipirosin API Production by Type (2018-2023)
5.1.2 Global Tildipirosin API Production by Type (2024-2029)
5.1.3 Global Tildipirosin API Production Market Share by Type (2018-2029)
5.2 Global Tildipirosin API Production Value by Type (2018-2029)
5.2.1 Global Tildipirosin API Production Value by Type (2018-2023)
5.2.2 Global Tildipirosin API Production Value by Type (2024-2029)
5.2.3 Global Tildipirosin API Production Value Market Share by Type (2018-2029)
5.3 Global Tildipirosin API Price by Type (2018-2029)
6 Segment by Application
6.1 Global Tildipirosin API Production by Application (2018-2029)
6.1.1 Global Tildipirosin API Production by Application (2018-2023)
6.1.2 Global Tildipirosin API Production by Application (2024-2029)
6.1.3 Global Tildipirosin API Production Market Share by Application (2018-2029)
6.2 Global Tildipirosin API Production Value by Application (2018-2029)
6.2.1 Global Tildipirosin API Production Value by Application (2018-2023)
6.2.2 Global Tildipirosin API Production Value by Application (2024-2029)
6.2.3 Global Tildipirosin API Production Value Market Share by Application (2018-2029)
6.3 Global Tildipirosin API Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Wuhan Belka Biomedical Co., Ltd.
7.1.1 Wuhan Belka Biomedical Co., Ltd. Tildipirosin API Corporation Information
7.1.2 Wuhan Belka Biomedical Co., Ltd. Tildipirosin API Product Portfolio
7.1.3 Wuhan Belka Biomedical Co., Ltd. Tildipirosin API Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Wuhan Belka Biomedical Co., Ltd. Main Business and Markets Served
7.1.5 Wuhan Belka Biomedical Co., Ltd. Recent Developments/Updates
7.2 Wuhan Kemilink Chemical Technology Co., Ltd.
7.2.1 Wuhan Kemilink Chemical Technology Co., Ltd. Tildipirosin API Corporation Information
7.2.2 Wuhan Kemilink Chemical Technology Co., Ltd. Tildipirosin API Product Portfolio
7.2.3 Wuhan Kemilink Chemical Technology Co., Ltd. Tildipirosin API Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Wuhan Kemilink Chemical Technology Co., Ltd. Main Business and Markets Served
7.2.5 Wuhan Kemilink Chemical Technology Co., Ltd. Recent Developments/Updates
7.3 BOC Sciences
7.3.1 BOC Sciences Tildipirosin API Corporation Information
7.3.2 BOC Sciences Tildipirosin API Product Portfolio
7.3.3 BOC Sciences Tildipirosin API Production, Value, Price and Gross Margin (2018-2023)
7.3.4 BOC Sciences Main Business and Markets Served
7.3.5 BOC Sciences Recent Developments/Updates
7.4 Cayman Chemical Company
7.4.1 Cayman Chemical Company Tildipirosin API Corporation Information
7.4.2 Cayman Chemical Company Tildipirosin API Product Portfolio
7.4.3 Cayman Chemical Company Tildipirosin API Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Cayman Chemical Company Main Business and Markets Served
7.4.5 Cayman Chemical Company Recent Developments/Updates
7.5 Biosynth Carbosynth
7.5.1 Biosynth Carbosynth Tildipirosin API Corporation Information
7.5.2 Biosynth Carbosynth Tildipirosin API Product Portfolio
7.5.3 Biosynth Carbosynth Tildipirosin API Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Biosynth Carbosynth Main Business and Markets Served
7.5.5 Biosynth Carbosynth Recent Developments/Updates
7.6 Wellman Pharmaceutical Group Co., Ltd.
7.6.1 Wellman Pharmaceutical Group Co., Ltd. Tildipirosin API Corporation Information
7.6.2 Wellman Pharmaceutical Group Co., Ltd. Tildipirosin API Product Portfolio
7.6.3 Wellman Pharmaceutical Group Co., Ltd. Tildipirosin API Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Wellman Pharmaceutical Group Co., Ltd. Main Business and Markets Served
7.6.5 Wellman Pharmaceutical Group Co., Ltd. Recent Developments/Updates
7.7 Wuhan Dingxintong Pharmaceutical Co., Ltd.
7.7.1 Wuhan Dingxintong Pharmaceutical Co., Ltd. Tildipirosin API Corporation Information
7.7.2 Wuhan Dingxintong Pharmaceutical Co., Ltd. Tildipirosin API Product Portfolio
7.7.3 Wuhan Dingxintong Pharmaceutical Co., Ltd. Tildipirosin API Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Wuhan Dingxintong Pharmaceutical Co., Ltd. Main Business and Markets Served
7.7.5 Wuhan Dingxintong Pharmaceutical Co., Ltd. Recent Developments/Updates
7.8 Shanghai Hanxiang Biological Technology Co., Ltd.
7.8.1 Shanghai Hanxiang Biological Technology Co., Ltd. Tildipirosin API Corporation Information
7.8.2 Shanghai Hanxiang Biological Technology Co., Ltd. Tildipirosin API Product Portfolio
7.8.3 Shanghai Hanxiang Biological Technology Co., Ltd. Tildipirosin API Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Shanghai Hanxiang Biological Technology Co., Ltd. Main Business and Markets Served
7.7.5 Shanghai Hanxiang Biological Technology Co., Ltd. Recent Developments/Updates
7.9 MedChemExpress
7.9.1 MedChemExpress Tildipirosin API Corporation Information
7.9.2 MedChemExpress Tildipirosin API Product Portfolio
7.9.3 MedChemExpress Tildipirosin API Production, Value, Price and Gross Margin (2018-2023)
7.9.4 MedChemExpress Main Business and Markets Served
7.9.5 MedChemExpress Recent Developments/Updates
7.10 Nanjing Kangmanlin Chemical Industry Co., Ltd.
7.10.1 Nanjing Kangmanlin Chemical Industry Co., Ltd. Tildipirosin API Corporation Information
7.10.2 Nanjing Kangmanlin Chemical Industry Co., Ltd. Tildipirosin API Product Portfolio
7.10.3 Nanjing Kangmanlin Chemical Industry Co., Ltd. Tildipirosin API Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Nanjing Kangmanlin Chemical Industry Co., Ltd. Main Business and Markets Served
7.10.5 Nanjing Kangmanlin Chemical Industry Co., Ltd. Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Tildipirosin API Industry Chain Analysis
8.2 Tildipirosin API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Tildipirosin API Production Mode & Process
8.4 Tildipirosin API Sales and Marketing
8.4.1 Tildipirosin API Sales Channels
8.4.2 Tildipirosin API Distributors
8.5 Tildipirosin API Customers
9 Tildipirosin API Market Dynamics
9.1 Tildipirosin API Industry Trends
9.2 Tildipirosin API Market Drivers
9.3 Tildipirosin API Market Challenges
9.4 Tildipirosin API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Wuhan Belka Biomedical Co., Ltd.
Wuhan Kemilink Chemical Technology Co., Ltd.
BOC Sciences
Cayman Chemical Company
Biosynth Carbosynth
Wellman Pharmaceutical Group Co., Ltd.
Wuhan Dingxintong Pharmaceutical Co., Ltd.
Shanghai Hanxiang Biological Technology Co., Ltd.
MedChemExpress
Nanjing Kangmanlin Chemical Industry Co., Ltd.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂